When California voters approved 3 billion dollars in bonds for stem-cell research, they weren’t told how long it might take to develop treatments for diseases that have no cures. That was in 2004, and the agency that was created is still trying to get research out of the lab and into the clinical phase. We’ll hear what the latest 150 million in grants are for and what it’s realistic to expect. Also… Apple and Samsung. When two giants of high technology go to court, what does it mean for struggling start-ups? Later on… high tech chemistry and the war on drugs…
FROM THIS EPISODE
California’s Institute for Regenerative Medicine is a unique state agency—with guaranteed funding of 3 billion dollars from bonds. It was created by the voters in 2004, when the Bush Administration opposed using embryonic stem cells for medical research. The promise was to develop treatments for incurable diseases but—whatever the voters thought 8 years ago—that takes a long time. Last week, the Institute passed out its latest grants—150 million dollars, in hopes of moving from laboratories into clinical trials. UCLA’s Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research got 20 million dollars last week from the Institute.
Alan Trounson, President of the California Institute for Regenerative Medicine (@CIRMnews)
Dr. Antoni Ribas, Professor of Medicine and a Scientist with the Broad Stem Cell Research Center, UCLA
In a San Jose federal court today, an attorney for Apple told jurors that internal documents show that Samsung made a specific decision to copy the iPhone because it could not compete on its own. It’s the start of a patent-infringement case that could take a month to try.
Synthetic drugs providing cheap highs that appear to be legal are being sold over the counter all over the country—and on the Internet. What are they? Also, India was again, struck by a massive power outage. On Reporter's Notebook, the Democratic Convention has unanimously voted to make same-sex marriage part of the platform.
Jeffrey Scott, Spokesperson for the DEA
Natasha Vargas-Cooper, Freelance Reporter (@natashavc)
Cindy Schaider, Executive Director of the Casa Grande Alliance
Maia Szalavitz, neuroscience journalist (@maiasz)